These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma. Moehrle M; Kraemer A; Schippert W; Garbe C; Rassner G; Breuninger H Br J Dermatol; 2004 Aug; 151(2):397-406. PubMed ID: 15327547 [TBL] [Abstract][Full Text] [Related]
46. Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Snoeren N; Jansen MC; Rijken AM; van Hillegersberg R; Slooter G; Klaase J; van den Tol PM; van der Linden E; Ten Kate FJ; van Gulik TM Dig Surg; 2009; 26(1):56-62. PubMed ID: 19169031 [TBL] [Abstract][Full Text] [Related]
47. [Factors contributing to local recurrences of skin melanomas after surgery]. Anismov VV Vopr Onkol; 1983; 29(9):16-20. PubMed ID: 6636624 [TBL] [Abstract][Full Text] [Related]
48. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188 [TBL] [Abstract][Full Text] [Related]
49. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma]. Fan J; Xu Y Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749 [No Abstract] [Full Text] [Related]
50. Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence. Buchman C; Stringer SP; Mendenhall WM; Parsons JT; Jordan JR; Cassisi NJ Laryngoscope; 1994 Oct; 104(10):1231-4. PubMed ID: 7934593 [TBL] [Abstract][Full Text] [Related]
51. [Therapeutic progress in tumor medicine, usable in general practice--in adult oncology]. Senn HJ Med Welt; 1979 Oct; 30(41):1495-501. PubMed ID: 92744 [No Abstract] [Full Text] [Related]
52. Recurrence at the operative site and its relation to cancer growth in mice. McCredie JA; Inch WR Can J Surg; 1966 Oct; 9(4):373-8. PubMed ID: 5923148 [No Abstract] [Full Text] [Related]
54. [Prevention, recognition and treatment of neoplasm recurrences from the surgeon's viewpoint]. Wittig G Zentralbl Chir; 1974 Apr; 99(16):481-90. PubMed ID: 4600816 [No Abstract] [Full Text] [Related]
55. Effects of topical chemotherapy in cancer surgery. A clinical study. Jones RF; Smith AL; Jones RC Cancer; 1968 Dec; 22(6):1250-3. PubMed ID: 5705786 [No Abstract] [Full Text] [Related]
56. Negative surgical margins: Main course or just icing on the cake? Kooby DA; Maithel SK J Surg Oncol; 2016 Mar; 113(3):247. PubMed ID: 27094455 [No Abstract] [Full Text] [Related]
57. Perioperative blood transfusion and recurrence of cancer: is there a direct association? Francis DM Aust N Z J Surg; 1990 Oct; 60(10):743-5. PubMed ID: 2403323 [No Abstract] [Full Text] [Related]
59. Ischemia-reperfusion injury and regrowth of liver cancers: to clamp or not to clamp? Lim C; Azoulay D Dig Dis Sci; 2014 Sep; 59(9):2030-1. PubMed ID: 25064213 [No Abstract] [Full Text] [Related]
60. Local and systemic recurrence is the Achilles heel of cancer surgery. Aliperti LA; Predina JD; Vachani A; Singhal S Ann Surg Oncol; 2011 Mar; 18(3):603-7. PubMed ID: 21161729 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]